Visceral obesity also correlates with metabolic syndrome—characterized by hypertension, diabetes mellitus, and dyslipidemia, all risk factors that also contribute to atherosclerosis—and increases plasminogen activator inhibitor-1 levels, making abdominal visceral fat a potential risk factor for mesenteric artery thrombosis [44]. The gene discussed is SERPINE1; the disease is metabolic syndrome.